Skip to content

Mahanimba Taila used for Sthanika Abhyanga and Nasya with Keshavardhini Rasayana for the management of Indralupta.

A Clinical Study to evaluate the effect of Mahanimba taila Nasya with Sthanika Abhyanga and Keshavardhini Rasayana sevana in the management of Indralupta W.S.R to Alopecia areata.(Randomised comparative clinical study) - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056185
Enrollment
40
Registered
2023-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Kavana K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients With Lakshanas Of INDRALUPTA 2.Patients Of age group between 16 to 60 years will be included irrespective of their gender,religion ,marital status and Socioeconomic status 3.Patients fit for STHANIKA ABHYANGA and NASYA KARMA 4.Localised hair loss in areas of scalp, beard,mustache

Exclusion criteria

Exclusion criteria: 1.Patients less than 16 and above 60 years of age 2.Patients having hereditary baldness or having history of hair loss due to injury 3.Patients suffering from any severe systemic disease 4.Patients unfit for STHANIKA ABHYANAGA and NASYA KARMA 5.ALOPECIA TOTALIS AND ALOPECIA UNIVERSALIS CASES

Design outcomes

Primary

MeasureTime frame
The total number of patches will be counted,size of patches will be measured.The hair growth will be assessed.Timepoint: 0TH,30TH,60TH,90TH

Secondary

MeasureTime frame
The Total no. of patches,size of patches reduced or aggrevated will be counted & measured.Timepoint: 60th,90TH day

Countries

India

Contacts

Public ContactDr Kulkarni Ashwini A

Dhanvantari Ayurveda College, Hospital and Research Center.Siddapur.(U.K)

ashwini.kulkarni15@gmail.com8879044624

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026